Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis

Journal of Neuroimmunology

Volumn 191, Issue 1-2, 2007, Pages 45-50

  Stuart, Rodney ^a   Lovett Racke, Amy E ^a   Frohman, Elliot M ^a   Hawker, Kathleen ^a   Racke, Michael K ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

CD152; Genetics; MS

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

CHI SQUARE TEST; CONTROLLED STUDY; DISEASE COURSE; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; EXONS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 35848945487     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.008     Document Type: Review

References (31)

1. Bagos P.G., Karnaouri A.C., Nikolopoulos G.K., and Hamodrakas S.J. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis. Mult. Scler. 13 (2007) 156-168
2. Berkow R. Multiple Sclerosis. The Merck Manual of Diagnosis and Therapy. Merck Research Laboratory 16 (1992) 1488-1490
3. Braun J., Donner H., Siegmund T., Walfish P.G., Usadel K.H., and Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens. 51 (1998) 563-566
4. Chataway J., Feakes R., Coraddu F., Gray J., Deans J., Fraser M., Robertson N., Broadley S., Jones H., Clayton D., Goodfellow P., Sawcer S., and Compston A. The genetics of multiple sclerosis: systematic genome screen. Brain 121 (1998) 1869-1887
5. Chuang E., Alegre M.L., Duckett C.S., Noel P.J., Vander Heiden M.G., and Thompson C.B. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159 (1997) 144-151
6. Cocco E., Mancosu C., Fadda E., Murru M.R., Costa G., Murru R., and Marrosu M.G. Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients. J Neurol. 249 (2002) 1552-1555
7. Dyment D.A., Sadovnick A.D., and Ebers G.C. Genetics of multiple sclerosis. Hum. Molec. Genet. 6 (1997) 1693-1698
8. Frohman E.M., Racke M.K., and Raine C.S. Multiple sclerosis: the plaque and its pathogenesis. New Engl. J. Med. 354 (2006) 942-955
9. Fukazawa T., Yanagawa T., Kikuchi S., Yabe I., Sasaki H., Hamada T., Miyasaka K., Gomi K., and Tashiro K. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. J. Neurol. Sci. 171 (1999) 49-55
10. Fukazawa T., Kikuchi K., Miyagishi R., Niino M., Yabe I., Hamada T., and Sasaki H. CTLA-4 gene polymorphism is not associated with conventional multiple sclerosis in Japanese. J. Neuroimmunol. 159 (2005) 225-229
11. Gomez-Lira M. Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis. Neuroimmunol. 133 (2002) 241-243
12. Gribben J.G., Freeman G.J., Boussiotis V.A., Rennert P., Jellis C.L., Greenfield E., Barber M., Restivo Jr. V.A., Ke X., Gray G.S., and Nadler L.M. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 811-815
13. Haaning Andersen A.D., Lange M., and Lillevang S.T. Allelic variation of the inducible costimulator (ICOS) gene: detection of polymorphisms, analysis of the promoter region, and extended haplotype estimation. Tissue Antigens. 61 (2003) 276-285
14. Haimila K., Smedberg T., Mustalahti K., Maki M., Partanen J., and Holopainen P. Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun. 5 (2004) 85-92
15. Haines J.L., Terwedow H.A., Burgess K., Pericak-Vance M.A., Rimmler J.B., Martin E.R., Oksenberg J.R., Lincoln R., Zhang D.Y., Banatao D.R., Gatto N., Goodkin D.E., and Hauser S.L. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum. Molec. Genet. 7 (1998) 1229-1234
16. Ihara K., Ahmed S., Nakao F., Kinukawa N., Kuromaru R., Matsuura N., Iwata I., Nagafuchi S., Kohno H., Miyako K., and Hara T. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 53 (2001) 447-454
17. Joy J.E., and Jonston R.B. Multiple Sclerosis: Current Status and Strategies for the Future (2001), National Academy Press, Washington 29-241
18. Kantarci O.H., Hebrink D.D., Achenbach S.J., Atkinson E.J., aliszewska A., Buckle G., McMurray C.T., de Andrade M., Hafler D.A., and Weinshenker B.G. CTLA4 is associated with susceptibility to multiple sclerosis. J. Neuroimmunol. 134 (2003) 133-141
19. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., and DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol. 165 (2000) 6606-6611
20. Kristiansen O.P., Larsen Z.M., and Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity. Genes Immun. 1 (2000) 170-184
21. Krummel M.F., and Allison J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183 (1996) 2533-2540
22. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., Wikstron J., Palo J., Stein L.D., Hudson T.J., Lander E.S., and Peltonen L. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61 (1997) 1379-1387
23. Ligers A., Xu C., Saarinen S., Hillert J., and lerup O. The CTLA-4 gene is associated with multiple sclerosis. J. Neuroimmunol. 97 (1999) 182-190
24. *15-negative families with multiple sclerosis. Am. J. Hum.Genet. 69 (2001) 900-903
25. Ligers A., Teleshova N., Masterman T., Huang W.X., and Hillert J. CTLA-gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2 (2001) 145-152
26. Lin S.C., Yen J.H., Tsai J.J., Tsai W.C., Ou T.T., Liu H.W., and Chen C.J. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 770-775
27. Nielsen C., Hansen D., Husby S., Jacobsen B.B., and Lillevang S.T. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens. 62 (2003) 492-497
28. Oksenberg J.R., Barcellos L.F., Cree B.A., Baranzini S.E., Bugawan T.L., Khan O., Lincoln R.R., Swerdlin A., Mignot E., Lin L., Goodin D., Erlich H.A., Schmidt S., Thomson G., Reich D.E., Pericak-Vance M.A., Haines J.L., and Hauser S.L. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am. J. Hum. Genet. 74 (2004) 160-167
29. Oliveira E.M.L., Bar-Or A., Waliszewska A.I., Cai G., Anderson D.E., Krieger J.I., and Hafler D.A. CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls. J. Autoimmun. 20 (2003) 71-82
30. Roxburgh R.H., Sawcer S., Maranian M., Seaman S., hensiek A., Yeo T., Deans J., and Compston A. No evidence of a significant role for CTLA-4 in multiple sclerosis. J. Neuroimmunol. 171 (2006) 193-197
31. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., and Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1 (1994) 405-413